http://elea.unisa.it/xmlui/handle/10556/1366 2026-04-20T11:16:22Z 2026-04-20T11:16:22Z Merolla, Giovanni Porcellini, Giuseppe http://elea.unisa.it/xmlui/handle/10556/1399 2025-04-30T14:13:45Z 2014-01-01T00:00:00Z

Reverse shoulder arthroplasty in patients aged sixty years old or younger: are we really doing the best? Merolla, Giovanni; Porcellini, Giuseppe

2014-01-01T00:00:00Z Aquino, Carmen Imma Nori, Stefania Lucia http://elea.unisa.it/xmlui/handle/10556/1398 2025-04-30T14:15:02Z 2014-01-01T00:00:00Z

Complementary Therapy in Polycystic Ovary Syndrome Aquino, Carmen Imma; Nori, Stefania Lucia Polycystic Ovary Syndrome (PCOS) is an endocrine disease. PCOS afflicts 5 to 10 % of women of reproductive age. The symptoms are: amenorrhea, oligomenorrhea, hirsutism, obesity, infertility, chronic hyperandrogenic anovulation and acne. Other risk factors aggravate this condition: insulin resistance, obesity, hypertension, dyslipidemia, inflammation and subclinical cardiovascular disease. Anxiety, depression and reduced quality of life are also common. This review highlights the mechanisms and the beneficial effects of acupuncture, exercise and resveratrol on animal models and on humans affected by PCOS.

2014-01-01T00:00:00Z Gangemi, Michelangelo Cavallo, Luigi Maria Di Somma, Alberto Mazzucco, Grazia Marina Bono, Paolo Sebastiano Ghetti, Giovanni Zambon, Giampaolo http://elea.unisa.it/xmlui/handle/10556/1397 2025-04-30T14:13:30Z 2014-01-01T00:00:00Z

Hydrocephalus onset after microsurgical or endovascular treatment for acute subarachnoid hemorrhage. Retrospective Italian Multicenter Study Gangemi, Michelangelo; Cavallo, Luigi Maria; Di Somma, Alberto; Mazzucco, Grazia Marina; Bono, Paolo Sebastiano; Ghetti, Giovanni; Zambon, Giampaolo Background: Chronic shunt-dependent hydrocephalus is a complication of aneurysmal subarachnoid hemorrhage (aSAH). Its incidence and risk factors have been described while the hydrocephalus onset in terms of days after treatment (microsurgical or endovascular) has not been yet analyzed. Materials and Methods: 45 patients, treated for aSAH in 4 Italian Neurosurgical Departments, were retrospectively analyzed. It was calculated the time that elapses between treatment and hydrocephalus onset in 36 patients. Results: Of the 45 shunted patients, 15 (33.3%) were included in the microsurgical group (group A) and 30 (66.6%) were in the endovascular one (group B). There was no difference of the hydrocephalus onset between the two groups (24,1 days, group A vs. 27,7 days, group B). The presence of intracerebral hematoma (ICH) caused a delay in the hydrocephalus onset after endovascular treatment in terms of 11,5 days compared to microsurgical group as well the absence of vasospasm determined a delay of 13,7 days (not statistically significant). Conclusion: No difference in terms of hydrocephalus onset after microsurgical or endovascular treatment has been demonstrated. Only the presence of ICH or the absence of vasospasm can cause a slight delay in the time of hydrocephalus onset in the endovascular series (not statistically significant). Long-term follow-up studies involving higher numbers of subjects are needed to better demonstrate this issue.

2014-01-01T00:00:00Z Alattar, Abdulhameed Ghani, Saqib Mahdy, N. Hussain, H. Maffulli, Nicola http://elea.unisa.it/xmlui/handle/10556/1396 2025-04-30T14:15:33Z 2014-01-01T00:00:00Z

Pre-Participation Musculoskeletal and Cardiac Screening of Male Athletes in the United Arab Emirates Alattar, Abdulhameed; Ghani, Saqib; Mahdy, N.; Hussain, H.; Maffulli, Nicola This study presents the results of pre-participation musculoskeletal and cardiac screening using the Lausanne recommendations, which include a personal and family history, physical examination and electrocardiography. Cross sectional study using the Lausanne screenings and the European Society of Cardiology (ESC) recommendations carried out at Al-Ahli club in Dubai, United Arab Emirates. 230 male athletes participating in organised sports were included. Exclusion criteria were those under 14 or over 35 years old, females and athletes with established cardiovascular disease. Primary outcome are the results of Lausanne screening with outline of the negative, positive and false positive results and number needed to screen. Secondary outcomes include the results of musculoskeletal and neurological screening. A total of 174 (76%) athletes had a negative screening result. Fifty-four athletes (23%) underwent additional testing. Forty-seven athletes (20.4%) had false positive screening results. Seven athletes (3%) had a positive screening result and four athletes (2%) were restricted from sport. The number of athletes needed to screen to detect one lethal cardiovascular condition was 33 athletes. The Lausanne recommendations are well suited for the United Arab Emirates. The number needed to screen to detect one athlete with serious cardiovascular disease is acceptable at 33.

2014-01-01T00:00:00Z